Einst und Jetzt im Fokus

Zürich (ots) - Der Publikumsrat SRG.D beschäftigte sich in der August-Sitzung einerseits mit «Tama ...

Dr. Hönle AG

euro adhoc: Dr. Hönle AG
Quarterly or Semiannual Financial Statements
Hönle continues to build up profits in the first half of the year (E)

--------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. ---------------------------------------------------------------------

Gräfelfing, Munich, 15 May, 2003

Dr. Hönle AG (ISIN: DE 0005157101), a leading UV technology systems provider, has further built up profits in the first half of financial year 2002/2003.

While consolidated sales rose by 17% to EUR 7,913 million in comparison to the previous year, net income for the first six months of the year climbed from EUR 0,178 million in the previous year’s period to EUR 1,004 million in the current financial year.

Earnings before interest, taxes, depreciation and amortization (EBITDA) increased in the first six months from EUR 0,058 million to EUR 0,687 million, and earnings before interest and taxes  (EBIT) from EUR -0,131 million to EUR 0,489 million. This corresponds to an EBIT margin of 6 percent. Earnings before taxes (EBT) amounted to EUR 0,884 million after being EUR 0,235 million in the previous year’s period.

This favourable result is, among other things, due to the fact that sales on the American UV market picked up significantly in comparison to the previous year and also because new, interesting UV applications such as the Ink Jet segment were opened up.

It is also very satisfactory that two of the new subsidiaries - Aladin GmbH and Honle Spain S.A. - contributed positively to income in the first six months of the year. After only 16 months of operations, Wellomer GmbH, founded in 2002, also forecasts a positive financial result.

In the coming quarter, the Hönle Group expects increasing sales compared to the third quarter of the previous year since Dr. Hönle AG’s order volume as at 31 March, 2003 is 39% up on the comparable previous year’s period, and Wellomer GmbH received a large order at the beginning of April.

end of announcement            euro adhoc 15.05.2003

Further inquiry note: For further information: www.hoenle.de, Contact: Dr. Hönle AG, Peter Weinert, Investor Relations Manager, Lochhamer Schlag 1, 82166 Gräfelfing, Munich, Tel.: +49 (0)89-85 608-173, Fax: +49 (0)89-85 608-148, E-Mail: ir@hoenle.de

Branche: Instrument Engineering
ISIN:      DE0005157101
WKN:        515710
Index:    CDAX Gesamtindex, CDAX Technology, Prime Standard
Börsen:  Frankfurter Wertpapierbörse / regulated dealing
              Niedersächsische Börse zu Hannover / free trade
              Berliner Wertpapierbörse / free trade
              Bayerische Börse / free trade
              Hamburger Wertpapierbörse / free trade
              Bremer Wertpapierbörse (BWB) / free trade
              Börse Düsseldorf / free trade
              Baden-Württembergische Wertpapierbörse / free trade

Das könnte Sie auch interessieren: